AvKARE is recalling 55,496 bottles of Cinacalcet Tablets in 30 mg, 60 mg, and 90 mg strengths because they were found to contain an impurity called N-Nitroso-Cinacalcet that exceeds acceptable levels. This prescription medication is used to treat secondary hyperparathyroidism or high calcium levels. The affected 30-count bottles were distributed nationwide in the United States and all have an expiration date of December 31, 2024.
N-Nitroso-Cinacalcet is a type of nitrosamine impurity which is classified as a probable human carcinogen. While no immediate health issues have been reported, long-term exposure to these impurities above acceptable limits may increase the risk of developing cancer.
You have 2 options:
Quantity: 50,304 bottles
Quantity: 2,396 bottles
Quantity: 2,796 bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.